D. S. Dolgasheva, A. M. Pevzner, M. K. Ibragimova, N. V. Litvyakov, & M. M. Tsyganov. (2020). PARP1 inhibitors in breast cancer therapy. Mechanism of action and clinical use. ABV-press.
Chicago Style (17th ed.) CitationD. S. Dolgasheva, A. M. Pevzner, M. K. Ibragimova, N. V. Litvyakov, and M. M. Tsyganov. PARP1 Inhibitors in Breast Cancer Therapy. Mechanism of Action and Clinical Use. ABV-press, 2020.
MLA (9th ed.) CitationD. S. Dolgasheva, et al. PARP1 Inhibitors in Breast Cancer Therapy. Mechanism of Action and Clinical Use. ABV-press, 2020.
Warning: These citations may not always be 100% accurate.